Msln−/− mice were protected by ≈50% from bleomycin-induced lung fibrosis as compared with wild-type mice, with reduced activation of Col-GFP+Thy1+ lung fibroblasts. The gene discussed is MSLN; the disease is pulmonary fibrosis.